Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· HRH.R. 7761 (116th)referred
United States · United States Congress · 23 July 2020
Protecting Access to Loan Forgiveness for Public Servants During the COVID-19 Pandemic Act This bill allows public service employees who are impacted by the COVID-19 (i.e., coronavirus disease 2019) public health emergency to continue to participate, without disruption, in the Public Service Loan Forgiveness (PSLF) program. Specifically, an individual who was employed in a public service job and who experiences lapse in employment (e.g., a furlough, a layoff, or the individual's resignation due to illness or caregiving responsibilities) because of the COVID-19 public health emergency may continue to participate in the PSLF program without disruption. The bill treats such an individual as employed in a public service job during the emergency and deems a monthly payment made by the individual as a qualifying monthly payment toward loan cancellation under the PSLF program. However, unless the individual would have completed requirements for loan cancellation during the public health emergency, the individual must resume employment in a public service job within six months after the end of the emergency. In addition, the bill directs the Department of Education to develop and make available guidance related to the assistance provided by the bill.
Bill· HRH.R. 7757 (116th)referred
United States · United States Congress · 23 July 2020
Long-Term Care Pharmacy Definition Act of 2020 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
Bill· HRH.R. 7759 (116th)referred
United States · United States Congress · 23 July 2020
Saving Rural Hospitals from Closure Act This bill modifies requirements for the Medicare Accelerated and Advance Payment Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The program provides Medicare payments in advance to eligible providers experiencing claims or cash flow disruptions, such as during national emergencies; the program was specifically expanded in response to COVID-19 to encompass more types of providers, subject to certain recoupment and repayment provisions. The bill allows the Centers for Medicare & Medicaid Services to forgive repayment, extend the recoupment timeline, and lower applicable interest rates for hospitals experiencing significant financial hardship (e.g., impending bankruptcy).
Bill· SS. 4293 (116th)referred
United States · United States Congress · 23 July 2020
Maintaining Important Distance During Lengthy Epidemics Act of 2020 or the MIDDLE Act of 2020 This bill prohibits air carriers, during the COVID-19 (i.e., coronavirus disease 2019) public health emergency, from (1) permitting adjacent seats to another occupied seat to be filled on a passenger aircraft, (2) passing along the cost of any seat switch undertaken by such air carriers in order to comply with the prohibitions, and (3) permitting a passenger or crewmember to board a passenger aircraft if the passenger or crewmember is not wearing a mask. The Federal Aviation Administration must issue guidance for appropriate exceptions to the prohibitions based on federal public health guidance.
Bill· SS. 4296 (116th)referred
United States · United States Congress · 23 July 2020
Drug-Free Communities Pandemic Relief Act This bill authorizes the Drug-Free Communities Support Program, subject to certain limitations, to waive matching funds requirements applicable to certain grants for reducing substance use among youth. Before waiving these requirements, the program must determine that a grantee is unable to raise funds because of the COVID-19 (i.e. coronavirus disease 2019) emergency. Currently, the Office of National Drug Control Policy administers this program, and community coalitions that receive the grants must match a specified percentage of the federal award amount with nonfederal funds, including in-kind contributions.
Bill· SS. 4295 (116th)referred
United States · United States Congress · 23 July 2020
Public Health Emergency Pass-Through Payment Fairness Act of 2020 This bill allows the Centers for Medicare & Medicaid Services to extend pass-through payments and categories for certain Medicare drugs and devices during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019).
Bill· SS. 4315 (116th)referred
United States · United States Congress · 23 July 2020
COVID-19 Testing, Reaching, And Contacting Everyone Act or the TRACE Act This bill authorizes the Centers for Disease Control and Prevention (CDC) to award grants for testing, contact tracing, monitoring, and other activities to address COVID-19 (i.e., coronavirus disease 2019). Entities such as federally qualified health centers, nonprofit organizations, and certain hospitals and schools are eligible to receive such grants. In awarding the grants, the CDC shall prioritize applicants that (1) operate in hot spots and medically underserved communities, and (2) agree to hire individuals from the communities where grant activities occur.
Resolution· SRESS.Res. 657 (116th)referred
United States · United States Congress · 23 July 2020
This resolution supports the goals of BIPOC Mental Health Awareness Month, including bringing attention to the mental health disparities faced by communities of color.
Bill· SS. 4313 (116th)referred
United States · United States Congress · 23 July 2020
Physician Education on PFAS Health Impacts Act This bill establishes a grant program within the Department of Health and Human Services (HHS) to educate health care providers about the health impacts of exposure to perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. Specifically, HHS must award grants to national or state medical organizations and other institutions that have expertise in diseases and conditions related to PFAS to provide these trainings.
Bill· HRH.R. 7718 (116th)referred
United States · United States Congress · 22 July 2020
Protecting the Health and Wellness of Babies and Pregnant Women in Custody Act This bill contains provisions related to the medical needs of incarcerated women. The Bureau of Prisons (BOP) shall provide women in its custody access to certain reproductive health services. The bill also requires the BOP to (1) comply with requirements related to the health of a pregnant incarcerated woman, such as providing appropriate meals and medical services; and (2) provide appropriate health care to a woman with a high-risk pregnancy. The bill also modifies restrictions on using restraints on an incarcerated woman during pregnancy, labor, or after delivery. The bill prohibits such restraints unless the relevant corrections official and a health care professional determine that the restraints are appropriate for the woman's medical safety. The health care professional must review this determination every six hours. The current statute allows using such restraints if the corrections official determines that restraints are needed due to a flight risk or threat of harm, and does not require periodic review. The bill also prohibits the BOP from placing a pregnant woman into restrictive housing, such as solitary confinement, unless the relevant corrections official determines that such an action is necessary to address a serious and immediate risk of physical harm. This determination shall be reviewed every four hours. The Department of Justice may make grants to eligible entities, such as a state department of corrections, to provide obstetrical care, gynecological care, and related services to women in custody. The Bureau of Justice Statistics shall collect certain data related to the health needs of pregnant incarcerated women.
Bill· HRH.R. 7732 (116th)referred
United States · United States Congress · 22 July 2020
How Awareness and Prevention Protect You Act This bill requires the Centers for Disease Control and Prevention (CDC) to undertake a public awareness campaign to increase knowledge of COVID-19 (i.e., coronavirus disease 2019), including the signs and symptoms of the disease and strategies to prevent transmission of the virus that causes it. The CDC must partner with community and faith-based organizations to carry out the campaign, which must be multilingual, culturally appropriate, and target populations with a high risk of contracting COVID-19.
Bill· HRH.R. 7722 (116th)referred
United States · United States Congress · 22 July 2020
Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge an uninsured individual who has diabetes the average net price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.
Bill· HRH.R. 7723 (116th)referred
United States · United States Congress · 22 July 2020
Behavioral Health Coordination and Communication Act of 2020 This bill establishes, within the Executive Office of the President, the position of Interagency Coordinator for Behavioral Health to coordinate federal programs and activities concerning mental health and substance use disorders. Federal departments and agencies must notify the coordinator when developing or implementing policies related to behavioral health. The Government Accountability Office must report on the impact of the coordinator on relevant programs and must study issues related to behavioral health services in school settings and in the juvenile justice system.
Bill· HRH.R. 7720 (116th)referred
United States · United States Congress · 22 July 2020
Helping Child Care Providers Respond to the Coronavirus Public Health Emergency Act of 2020 This bill authorizes child care providers to use payments received through the Child Care and Development Fund for sanitization and other costs associated with the COVID-19 (i.e., coronavirus disease 2019) public health emergency.
Bill· SS. 4261 (116th)referred
United States · United States Congress · 22 July 2020
Safely Creating Healthy Opening Options Locally Act or the SCHOOL Act This bill establishes a grant program and other resources to assist local educational agencies (LEAs) with reopening schools after closures related to COVID-19 (i.e., coronavirus disease 2019). Specifically, the Department of Education (ED) must partner with the Department of Health and Human Services (HHS) to award grants to LEAs for certain activities to reopen schools. These activities include (1) purchasing personal protective equipment; (2) cleaning and disinfecting schools; (3) purchasing the supplies necessary to carry out their reopening plans; and (4) complying with the guidelines, recommendations, and other public health communications issued by the Centers for Disease Control and Prevention and other entities to mitigate the hazards of COVID-19. Additionally, ED and HHS must (1) develop a process to connect health care professionals with schools to assist them with symptom checks and additional supports, and (2) develop recommendations to expand telehealth services to students and teachers in areas with a shortage of health care professionals. Further, HHS must issue guidance to clarify that private health insurance must cover COVID-19 testing, without imposing cost-sharing, through telehealth services in school-based settings. The Centers for Medicare & Medicaid Services must issue a letter to advise states on providing coverage for telehealth services in school-based settings under Medicaid and the Children's Health Insurance Program. Finally, ED must develop an online clearinghouse to collect and maintain evidence-based information, including best practices, related to reopening schools after closures due to COVID-19.
Bill· SS. 4280 (116th)referred
United States · United States Congress · 22 July 2020
Preventing Health Emergencies And Temperature-related Illness and Deaths Act of 2020 or the Preventing HEAT Illness and Deaths Act of 2020 This bill establishes the National Integrated Heat Health Information System Interagency Committee, which shall focus on reducing the health risks of extreme heat over multiple time scales. The committee must, among other activities (1) develop a strategic plan to coordinate a federal approach to reducing health risks of heat; (2) study health-affected communities, including data collection, warning communications, resiliency, and response capacity; and (3) administer matching grants to increase awareness of heat risks and for projects, such as urban forestry, to reduce the health impacts of extreme heat events. To support the committee's activities, the National Oceanic and Atmospheric Administration shall provide administrative and technical assistance.
Bill· SS. 4274 (116th)referred
United States · United States Congress · 22 July 2020
Legalizing Drug Discounts for Seniors Act of 2020 This bill excludes certain discounts for covered drugs under the Medicare prescription drug benefit from the federal anti-kickback statute.
Bill· SS. 4269 (116th)referred
United States · United States Congress · 22 July 2020
Mothers and Newborns Success Act This bill directs the Health Resources Services Administration (HRSA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) to take certain actions to improve, and reduce racial, ethnic, and geographic disparities in, maternal health outcomes. First, with respect to HRSA, the bill provides statutory authority for grants that support (1) state efforts to reduce disparities in maternal health; and (2) increased access to maternal and obstetrics care in rural areas, including through telehealth. HRSA must also award grants to identify best practices to improve pregnancy and postpartum outcomes. Second, the bill authorizes the CDC to establish or expand, and provide technical assistance on capturing racial and other demographic data related to, maternal health data collection. It also expands the scope of safe motherhood grants awarded to government health departments to include (1) classifying birthing facilities based on the level of maternal and neonatal care the facilities provide, and (2) improving the validity of pregnancy data on death certificates. In addition, the CDC must award grants for a campaign targeting health care providers and the public to increase awareness of maternal and child health issues. Lastly, the NIH must establish the National Maternal Health Research Network to support efforts to improve diagnostics and clinical treatments, improve health outcomes, and reduce inequities to reduce maternal mortality and promote maternal health.
Bill· SS. 4268 (116th)referred
United States · United States Congress · 22 July 2020
Employer Assistance Coordination Act This bill permits certain small employers who participate in the Payroll Protection Program established to assist such employers adversely affected by the COVID-19 (i.e., coronavirus disease 2019) public health emergency to also claim the refundable employee retention tax credit if their businesses have experienced a significant reduction in revenue or have closed pursuant to a government order. The bill prohibits employers from using funds from both programs based upon the same wages paid to their employees.
Bill· SS. 4262 (116th)referred
United States · United States Congress · 22 July 2020
COVID-19 Health Disparities Action Act of 2020 This bill directs the Centers for Disease Control and Prevention (CDC) to award grants, and the Office of Minority Health (OMH) to develop a plan, to address health disparities related to COVID-19 (i.e., coronavirus disease 2019). Specifically, the CDC, in coordination with certain departments and agencies, must award grants for contact tracing to, among others, public health departments and health care providers. In awarding these grants, the CDC shall prioritize entities with a demonstrated commitment to employing individuals who represent the demographic groups in the community served by the entity. The CDC must also work with states to update certain COVID-19 testing plans to address testing for populations experiencing COVID-19 health disparities. Additionally, the CDC must award grants to public health departments, tribal organizations, and others for public awareness campaigns on COVID-19 health disparities and, upon the availability of a vaccine, COVID-19 vaccine safety. For these grants, the CDC must give priority to entities serving populations that experience COVID-19 health disparities and low rates of vaccinations, respectively. The CDC must undertake a separate COVID-19 public awareness campaign, as well. In addition, the OMH must develop, within 30 days, an action plan on COVID-19 health disparities that addresses, among other issues, barriers to COVID-19 data collection. The OMH must coordinate with the CDC and others on this plan and update it at least every 30 days during the COVID-19 emergency.
Resolution· SRESS.Res. 655 (116th)referred
United States · United States Congress · 22 July 2020
This resolution declares racism a public health crisis and supports efforts to address health disparities and inequities across all sectors.
Bill· SS. 4282 (116th)referred
United States · United States Congress · 22 July 2020
Crisis Care Improvement and Suicide Prevention Act of 2020 This bill requires states to support evidence-based crisis care services, such as crisis call centers, through the Community Mental Health Services Block Grant. In addition, for each year in which the appropriations for that grant exceed a specified amount, states must expend a certain percentage of their grant allotments on crisis care services.
Bill· SS. 4259 (116th)referred
United States · United States Congress · 22 July 2020
Long-Term Care Pharmacy Definition Act of 2020 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
Bill· SS. 4289 (116th)referred
United States · United States Congress · 22 July 2020
COVID-19 Emergency Telehealth Impact Reporting Act of 2020 This bill requires the Department of Health and Human Services (HHS) to analyze the impact of expanded Medicare telehealth services that were authorized through emergency waivers related to the COVID-19 (i.e., coronavirus disease 2019) pandemic. In developing this analysis, HHS must seek input from the Medicare Payment Advisory Commission, the Medicaid and CHIP Payment and Access Commission, and other stakeholders. Additionally, the final report of the analysis must include conclusions about the impact of telehealth on health care delivery and estimates for Medicare spending on telehealth during the COVID-19 emergency.
Bill· HRH.R. 7708 (116th)referred
United States · United States Congress · 21 July 2020
Defend COVID Research from Hackers Act This bill authorizes the President to impose visa-blocking, property-blocking, or economic sanctions on a foreign person that is involved in activities that are reasonably likely to result in a significant threat to U.S. national security, foreign policy, public health, economic health, or financial stability. The Department of State must submit a report detailing the extent of known or attempted cyber-enabled activities by foreign persons related to COVID-19 (i.e., coronavirus disease 2019) and assessing whether those activities qualify for the imposition of sanctions. Further, the bill provides penalties for a person who knowingly traffics in access to a protected computer if the trafficker knows the protected computer has been damaged in a prohibited manner. The bill also authorizes an injunction against a person who causes damage through accessing a protected computer or transmitting a program, information, code, or command to a protected computer.
Bill· HRH.R. 7701 (116th)referred
United States · United States Congress · 21 July 2020
Addiction Prevention and Responsible Opioid Practices Act This bill addresses substance use and mental health related to opiods, including by imposing an excise tax on opioids; modifying controlled substances regulations, prescription drug monitoring programs (PDMPs), and health insurance coverage; and requiring other activities. Specifically, the bill (1) establishes federal licensure requirements for pharmaceutical representatives who market opioids, (2) requires certain training and PDMP participation as conditions for controlled substance registration, and (3) withdraws regulatory approval for opioids with ultra-high doses. In addition, as a condition for receiving certain grants, recipients must, for example, mandate the use of PDMPs in specified ways and increase data-sharing. Additionally, to meet certain certification standards, health information technology must be interoperable with PDMPs. Additionally, the Centers for Medicare & Medicaid Services (CMS) must reimburse mental health services provided through telehealth under Medicare and develop a web-based tool to compare opioid prescribing in state Medicaid programs. The bill also creates grants to support compliance with requirements to provide parity in insurance coverage for mental health and substance use disorder services. The Government Accountability Office must study health care coverage and reimbursements for substance use disorder treatments. Furthermore, the Department of Health and Human Services and the CMS must develop quality measures and guidelines for treatment of non-fatal overdoses, and the Department of Justice must operate a drug take-back program. The National Academies of Sciences, Engineering, and Medicine and medical and dental schools must also report on Medicare coverage of non-opioid treatment for back pain and educational courses on pain management and opioid prescribing practices, respectively.
Bill· HRH.R. 7706 (116th)referred
United States · United States Congress · 21 July 2020
National Emergency Student Vote Act This bill requires institutions of higher education (IHEs) that participate in federal student-aid programs to provide students with additional resources on registering to vote. In addition, IHEs must provide students who are off campus due to a public health emergency with resources on voting by mail (e.g., absentee ballot applications).
Resolution· HRESH.Res. 1057 (116th)referred
United States · United States Congress · 21 July 2020
This resolution expresses the sense of the House of Representatives that investments in mental health care and substance use disorder care are necessary to address the high prevalence of those suffering from behavioral health conditions. It also recognizes the need for health care reform to integrate mental health care and substance use disorder treatment in the health care system.
Resolution· HRESH.Res. 1059 (116th)referred
United States · United States Congress · 21 July 2020
This resolution expresses support for the goals and ideals of National Clinicians HIV/AIDS Testing and Awareness Day.
Bill· HRH.R. 7695 (116th)referred
United States · United States Congress · 21 July 2020
COVID-19 Emergency Telehealth Impact Reporting Act of 2020 This bill requires the Department of Health and Human Services (HHS) to analyze the impact of expanded Medicare telehealth services that were authorized through emergency waivers related to the COVID-19 (i.e., coronavirus disease 2019) pandemic. In developing this analysis, HHS must seek input from the Medicare Payment Advisory Commission, the Medicaid and CHIP Payment and Access Commission, and other stakeholders. Additionally, the final report of the analysis must include conclusions about the impact of telehealth on health care delivery and estimates for Medicare spending on telehealth during the COVID-19 emergency.
Bill· SS. 4249 (116th)referred
United States · United States Congress · 21 July 2020
This bill prohibits the use of genetic material collected as a result of a COVID-19 (i.e., coronavirus disease 2019) test for any other purpose without the written, informed consent of the individual being tested. A person who violates this prohibition is subject to a civil monetary penalty of not more than $100 for each violation.
Bill· SS. 4242 (116th)referred
United States · United States Congress · 21 July 2020
Addiction Prevention and Responsible Opioid Practices Act This bill addresses substance use and mental health related to opiods, including by imposing an excise tax on opioids; modifying controlled substances regulations, prescription drug monitoring programs (PDMPs), and health insurance coverage; and requiring other activities. Specifically, the bill (1) establishes federal licensure requirements for pharmaceutical representatives who market opioids, (2) requires certain training and PDMP participation as conditions for controlled substance registration, and (3) withdraws regulatory approval for opioids with ultra-high doses. In addition, as a condition for receiving certain grants, recipients must, for example, mandate the use of PDMPs in specified ways and increase data-sharing. Additionally, to meet certain certification standards, health information technology must be interoperable with PDMPs. Additionally, the Centers for Medicare & Medicaid Services (CMS) must reimburse mental health services provided through telehealth under Medicare and develop a web-based tool to compare opioid prescribing in state Medicaid programs. The bill also creates grants to support compliance with requirements to provide parity in insurance coverage for mental health and substance use disorder services. The Government Accountability Office must study health care coverage and reimbursements for substance use disorder treatments. Furthermore, the Department of Health and Human Services and the CMS must develop quality measures and guidelines for treatment of non-fatal overdoses, and the Department of Justice must operate a drug take-back program. The National Academies of Sciences, Engineering, and Medicine and medical and dental schools must also report on Medicare coverage of non-opioid treatment for back pain and educational courses on pain management and opioid prescribing practices, respectively.
Bill· SS. 4254 (116th)referred
United States · United States Congress · 21 July 2020
National Emergency Student Vote Act This bill requires institutions of higher education (IHEs) that participate in federal student-aid programs to provide students with additional resources on registering to vote. In addition, IHEs must provide students who are off campus due to a public health emergency with resources on voting by mail (e.g., absentee ballot applications).
Bill· SS. 4253 (116th)referred
United States · United States Congress · 21 July 2020
Second Look at Drug Patents Act of 2020 This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.
Bill· SS. 4248 (116th)referred
United States · United States Congress · 21 July 2020
COVID-19 Bias and Anti-Racism Training Act of 2020 This bill requires the Department of Health and Human Services (HHS) to award grants to health care providers, public health departments, tribal organizations, schools for social workers and health professionals, and other nonprofit entities for bias and anti-racism training to reduce disparities in COVID-19 (i.e., coronavirus disease 2019) response efforts. In administering these grants, HHS must give priority to, among others, recipients in communities with racial and ethnic disparities in COVID-19 infections, hospitalizations, and death rates. In addition, HHS must develop requirements for bias and anti-racism training that aligns with continuing education requirements of applicable state licensing bodies, such as medical boards.
Bill· SS. 4246 (116th)referred
United States · United States Congress · 21 July 2020
Protect Access to Birth Control Act This bill nullifies interim final rules issued by the Department of Labor, the Department of the Treasury, and the Department of Health and Human Services that allow employers with religious or moral objections to be exempt from the requirement that their health insurance plans cover contraceptive services without cost-sharing.
Bill· HRH.R. 7687 (116th)referred
United States · United States Congress · 20 July 2020
Protecting Firefighters from PFAS Act This bill addresses firefighter and veteran exposure to perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds (e.g., weatherproof clothing). The bill authorizes the use of pre-disaster hazard mitigation funding for the remediation of PFAS at fire training facilities. The National Institute of Standards and Technology in the Department of Commerce must commence a study and report on the contents and composition of new and unused personal protective equipment worn by firefighters in relation to PFAS. For certain conditions associated with exposure to PFAS, the bill provides eligibility for Department of Veterans Affairs (VA) hospital care and medical services to veterans who served on active duty at military installations at which individuals were exposed to PFAS. Service by veterans as reservists or civilian firefighters shall be considered active duty service for eligibility purposes if such service occurred during a period specified by the VA on the applicable military installations. The bill also provides eligibility for VA hospital care and medical services for exposure-related conditions to the family members of such veterans and civilian firefighters. The bill establishes a presumption of service-connection for specified illnesses or diseases related to PFAS exposure that manifest in veterans (including reservists or veterans serving as civilian firefighters) who served on active duty at a military installation where they were exposed to PFAS. Under a presumption of service-connection, specific conditions diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded.
Bill· HRH.R. 7689 (116th)referred
United States · United States Congress · 20 July 2020
Improving Data Collection for Adverse Childhood Experiences Act This bill authorizes the Centers for Disease Control and Prevention (CDC) to collect data, in cooperation with states, through relevant public health surveillance systems or surveys for a longitudinal study on the links between adverse childhood experiences and negative outcomes. In addition, the CDC may provide, directly or through grants or other agreements with public or nonprofit entities, technical assistance related to this data collection.
Bill· HRH.R. 7692 (116th)referred
United States · United States Congress · 20 July 2020
Reopen Schools Safely Act This bill requires the Department of Education (ED) to award grants to states and, through them, subgrants to local educational agencies and institutions of higher education to comply with the guidelines, recommendations, and other public health communications issued by the Centers for Disease Control and Prevention and state and local governments to mitigate the hazards of COVID-19 (i.e., coronavirus disease 2019) in schools. Subgrants must be used for certain activities, such as implementing exposure control plans, hiring personnel and purchasing equipment for health screenings, providing students and staff with personal protective equipment, and purchasing sanitation supplies. Unexpended funds must be returned to ED. Additionally, unused supplies and materials that were purchased with grants may not be resold.
Bill· HRH.R. 7686 (116th)referred
United States · United States Congress · 20 July 2020
COVID-19 Essential Workers Compensation Fund Act of 2020 This bill provides funding to compensate essential frontline workers who were seriously injured or died as a result of COVID-19 (i.e., coronavirus disease 2019) through a temporary program within the Department of Health and Human Services (HHS). To obtain compensation, a worker or decedent's representative must file a claim with the Special Master appointed by HHS to administer the program. The Special Master must, within 120 days, review and make a decision concerning the claim, including making relevant determinations of economic and noneconomic losses. A claimant may appeal this decision to an Eligibility Committee established for this and other purposes. Compensation payments shall be made within 20 days of the Special Master's decision. The program terminates on January 1, 2035.
Bill· HRH.R. 7674 (116th)referred
United States · United States Congress · 20 July 2020
COVID-19 Data Transparency Act This bill requires the Centers for Disease Control and Prevention (CDC) to standardize reporting by government health departments of COVID-19 data, including information related to hospital admissions, testing, contact tracing, and transmission rates. In addition, the CDC must publicly post and periodically update this information on its website with individually identifiable information excluded.
Bill· HRH.R. 7671 (116th)referred
United States · United States Congress · 20 July 2020
Small Business Comeback Act This bill establishes a recovery compensation program whereby the Department of the Treasury shall authorize specified payments to certain small businesses to support their recovery from the COVID-19 (i.e., coronavirus disease 2019) pandemic. Treasury must appoint a Special Administrator to oversee the recovery compensation program, and the administrator must develop an application form that is simple to file and audit that applicants shall use when seeking recovery compensation. The maximum amount of recovery compensation an applicant may receive shall be the lesser of their average payment for total monthly expenses or $50 million. Among other requirements, an eligible entity must (1) be in an impaired sector as defined by the administrator; (2) have significant operations in, and a majority of its employees based in, the United States; and (3) continue to pay salaries or wages to employees who tested positive for COVID-19 or were exposed to COVID-19 in the workplace. Allowable uses of recovery compensation include (1) payroll costs; (2) costs related to the continuation of group health care benefits; (3) insurance premiums; (4) paycheck protection loan and economic injury disaster loan repayment obligations; and (5) federal, state, and local tax obligations. The bill also establishes the Special Inspector General for COVID-19 Recovery Funds, who shall conduct, supervise, and coordinate audits and investigations of the payment of recovery compensation. The bill further establishes the Congressional Oversight Board, which shall oversee the implementation of the recovery compensation program.
Bill· HRH.R. 7676 (116th)referred
United States · United States Congress · 20 July 2020
Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act This bill revises the format in which hospitals must list their standard charges for items and services to require that such lists are in a machine-readable format; it also revises the transparency requirements related to the costs of items and services for health insurance plans seeking certification as qualified health plans through insurance exchanges.
Bill· SS. 4230 (116th)referred
United States · United States Congress · 20 July 2020
Telehealth Expansion Act of 2020 This bill permanently excludes mental health services and certain evaluation and management services that are furnished via telehealth from certain originating site requirements under Medicare. Under current law, these telehealth services are excluded from such requirements through the end of the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019).
Bill· SS. 4231 (116th)referred
United States · United States Congress · 20 July 2020
Preparing for the Next Pandemic Act This bill provides funding to the Biomedical Advanced Research and Development Authority (BARDA) for activities to expand domestic manufacturing of medical countermeasures and to the Office of the Assistant Secretary for Preparedness and Response for grants to establish state stockpiles of medical supplies for use during public health emergencies. These funds are designated as an emergency requirement, which exempts them from discretionary spending limits and other budget enforcement rules. The bill also makes other changes to BARDA's authorities and duties with respect to countermeasures and the administration of the Strategic National Stockpile.
Bill· SS. 4216 (116th)referred
United States · United States Congress · 20 July 2020
Knowing the Efficiency and Efficacy of Permanent Telehealth Options Act of 2020 or the KEEP Telehealth Options Act of 2020 This bill requires the Department of Health and Human Services (HHS) and the Government Accountability Office (GAO) to report on the availability and effects of expanded telehealth services under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Among other information, HHS must detail its actions during the emergency to expand access to telehealth services and must analyze telehealth usage by certain demographic groups. The GAO must report on the efficiency and management of the telehealth expansion and related risks of fraudulent activity.
Bill· SS. 4225 (116th)referred
United States · United States Congress · 20 July 2020
Safeguarding Therapeutics Act of 2020 This bill authorizes the Food and Drug Administration to destroy imported counterfeit medical devices.
Bill· SS. 4232 (116th)referred
United States · United States Congress · 20 July 2020
This bill extends through December 30, 2022, the coverage period for the Coronavirus Relief Fund to make payments to tribal governments for necessary expenditures incurred as a result of the COVID-19 (i.e., coronavirus disease 2019) public health emergency.
Bill· HRH.R. 7651 (116th)referred
United States · United States Congress · 16 July 2020
Healthy Skies Act This bill requires the Transportation Security Administration (TSA) to conduct a pilot program at a minimum of 10 airports to establish and test procedures to screen all passengers for their temperatures before such passengers proceed through security into the sterile area. If the temperature of a passenger exceeds the guidance for what constitutes a fever issued by the Centers for Disease Control and Prevention (CDC) at the time such temperature screening is carried out, the TSA shall not permit such passenger to enter the sterile area. The TSA shall consider a resolution process for identifying medical conditions unrelated to COVID-19 (i.e., coronavirus disease 2019) that could result in a temperature that exceeds CDC guidance. The pilot program terminates on the date of the termination of the COVID-19 public health emergency.
Bill· HRH.R. 7618 (116th)referred
United States · United States Congress · 16 July 2020
COVID-19 Bias and Anti-Racism Training Act of 2020 This bill requires the Department of Health and Human Services (HHS) to award grants to health care providers, public health departments, tribal organizations, schools for social workers and health professionals, and other nonprofit entities for bias and anti-racism training to reduce disparities in COVID-19 (i.e., coronavirus disease 2019) response efforts. In administering these grants, HHS must give priority to, among others, recipients in communities with racial and ethnic disparities in COVID-19 infections, hospitalizations, and death rates. In addition, HHS must develop requirements for bias and anti-racism training that aligns with continuing education requirements of applicable state licensing bodies, such as medical boards.
PreviousPage 11 of 12Next